Herbas VPB

Print
EN | LT
LT - Glutamo rūgšties dekarboksilazė (GAD), skirta panaudoti autoimuninės ligos gydyme
EN - GLUTAMIC ACID DECARBOXYLASE (GAD) FOR USE IN THE TREATMENT OF AN AUTOIMMUNE DISEASE

Legal status

Patent in force

Claims | Licences
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/51 (2006.01)
A61K 39/00 (2006.01)
A61K 31/592 (2006.01)
A61K 31/593 (2006.01)
A61P 37/06 (2006.01)
A61P 3/10 (2006.01)
European patent
(11) Number of the document 3151853
(13) Kind of document T
(96) European patent application number 15802815.9
Date of filing the European patent application 2015-06-04
(97) Date of publication of the European application 2017-04-12
(45) Date of publication and mention of the grant of the patent 2020-05-06
(46) Date of publication of the claims translation 2020-08-10
PCT application
(86) Number PCT/SE2015/050651
Date 2015-06-04
PCT application publication
(87) Number WO 2015/187087
Date 2015-12-10
Priority applications
(30) Number Date Country code
1450678 2014-06-04 SE
1451315 2014-11-04 SE
Inventors
(72)
ESSEN-MÖLLER, Anders, SE
LUDVIGSSON, Johnny, SE
Grantee
(73) Diamyd Medical AB, Kungsgatan 29, 111 56 Stockholm, SE
Attorney or representative
(74) Otilija KLIMAITIENĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Glutamo rūgšties dekarboksilazė (GAD), skirta panaudoti autoimuninės ligos gydyme
  GLUTAMIC ACID DECARBOXYLASE (GAD) FOR USE IN THE TREATMENT OF AN AUTOIMMUNE DISEASE
Last renewal fee
Payment date Validity (years) Amount
2025-04-04 11 289.00 EUR
Next renewal fee
2026-06-04
Last update date 2025-04-08